Effects of Transferring to the Rehabilitation Ward on Long-Term Mortality Rate of First-Time Stroke Survivors: A Population-Based Study

2017 ◽  
Vol 98 (12) ◽  
pp. 2399-2407 ◽  
Author(s):  
Chien-Min Chen ◽  
Yao-Hsu Yang ◽  
Chia-Hao Chang ◽  
Pau-Chung Chen
2021 ◽  
Author(s):  
Milad Fahim ◽  
Lea M. Dijksman ◽  
Thijs A. Burghgraef ◽  
Paul B. van der Nat ◽  
Wouter J.M. Derksen ◽  
...  

2019 ◽  
Vol 54 (5) ◽  
pp. 1900804 ◽  
Author(s):  
Hyun Lee ◽  
Jiin Ryu ◽  
Eunwoo Nam ◽  
Sung Jun Chung ◽  
Yoomi Yeo ◽  
...  

IntroductionChronic systemic corticosteroid (CS) therapy is associated with an increased risk of mortality in patients with many chronic diseases. However, it has not been elucidated whether chronic systemic CS therapy is associated with increased mortality in patients with asthma. The aim of this study was to determine the effects of chronic systemic CS therapy on long-term mortality in adult patients with asthma.MethodsA population-based matched cohort study of males and females aged ≥18 years with asthma was performed using the Korean National Health Insurance Service database from 2005 to 2015. Hazard ratio (HR) with 95% confidence interval for all-cause mortality among patients in the CS-dependent cohort (CS use ≥6 months during baseline period) relative to those in the CS-independent cohort (CS use <6 months during baseline period) was evaluated.ResultsThe baseline cohort included 466 941 patients with asthma, of whom 8334 were CS-dependent and 458 607 were CS-independent. After 1:1 matching, 8334 subjects with CS-independent asthma were identified. The HR of mortality associated with CS-dependent asthma relative to CS-independent asthma was 2.17 (95% CI 2.04–2.31). In patients receiving low-dose CS, the HR was 1.84 (95% CI 1.69–2.00); in patients receiving high-dose CS, the HR was 2.56 (95% CI 2.35–2.80).ConclusionsIn this real-world, clinical practice, observational study, chronic use of systemic CS was associated with increased risk of mortality in patients with asthma, with a significant dose–response relationship between systemic CS use and long-term mortality.


2017 ◽  
Vol 49 (5) ◽  
pp. 365-372 ◽  
Author(s):  
Hans Kristian Floeystad ◽  
Are Holm ◽  
Leiv Sandvik ◽  
Didrik Frimann Vestrheim ◽  
Bjorn Brandsaeter ◽  
...  

2015 ◽  
Vol 93 (6) ◽  
pp. 400-406 ◽  
Author(s):  
Janine M Duke ◽  
James H Boyd ◽  
Suzanne Rea ◽  
Sean M Randall ◽  
Fiona M Wood

Epilepsia ◽  
2018 ◽  
Vol 60 (1) ◽  
pp. 33-41 ◽  
Author(s):  
Emmely Rodin ◽  
Martin H. Krogstad ◽  
Preben Aukland ◽  
Martin Lando ◽  
Harald S. Møller ◽  
...  

2014 ◽  
Vol 22 (4) ◽  
pp. 321-331 ◽  
Author(s):  
Ellen Melbye Langballe ◽  
Bo Engdahl ◽  
Hedvig Nordeng ◽  
Clive Ballard ◽  
Dag Aarsland ◽  
...  

2016 ◽  
Vol 31 (6) ◽  
pp. 1163-1169 ◽  
Author(s):  
Hilal Maradit Kremers ◽  
Dirk R. Larson ◽  
Mohamed Noureldin ◽  
Cathy D. Schleck ◽  
William A. Jiranek ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document